Hariri, Susan <br/><br/>
Response to Pendleton et al. regarding reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States.  [electronic resource] 

 -  Vaccine  Jan 2016 
 - 201 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2015.10.138  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma in Situ--prevention & control<br/>Female<br/>Human papillomavirus 16--isolation & purification<br/>Human papillomavirus 18--isolation & purification<br/>Humans<br/>Papillomavirus Vaccines--therapeutic use<br/>Uterine Cervical Diseases--prevention & control<br/>Uterine Cervical Dysplasia--prevention & control